ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 666295 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 666295; 2) Community: the network communities that were significantly associated with the response to NSC 666295; 3) Molecule: the relationships between components within communities and NSC 666295; 4) MDR: the compounds that were significantly associated with the NSC 666295.

NSC Compound Enrichment Correlation
NSC 180973 Tamoxifen citrate 0.0467178916101842 0.27448506
NSC 201290 Octadecanamide, N-(1.beta.-D-arabinofuranosyl-1,2-dihydro-2-oxo-4-pyrimidinyl)- 0.0467178916101842 0.34760025
NSC 24030 p-Phenylenediamine (8CI), N-butyl-N'-phenyl- 0.0467178916101842 0.36808704
NSC 279503 ISOBRUCEIN A 0.0467178916101842 0.3258094
NSC 318807 1H-Azepine-1-carbothioic acid, hexahydro-, [1-(2- pyridinyl)ethylidene]hydrazide 0.0467178916101842 0.43088914
NSC 320877 Geldanamycin, 17-[(2-chloroethyl)amino]-17-demethoxy- 0.0467178916101842 0.49341104
NSC 353739 Bismuthine, (acetyloxy)diphenyl- 0.0467178916101842 0.47320377
NSC 362453 Butanedioic acid, mono[2-[3,4-bis(4-chlorophenyl)-5-cyano-6-oxo-1(6H)-pyridazinyl]ethyl] ester 0.0467178916101842 0.36160858
NSC 382035 2,4-Pyrimidinediamine, 6-ethyl-5-[4-[methyl(phenylmethyl) amino]-3-nitrophenyl]- 0.0467178916101842 0.56688785
NSC 46683 Null 0.0467178916101842 0.25296511
Total:148  Current:135    [First] [Prev] [Next] [Last]